Mario J. Verdolini
Lawyers
Filters
Atara Biotherapeutics $175 million common stock and pre-funded warrants offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $175 million SEC-registered common stock and pre-funded warrants…
Seer $336 million IPO and concurrent private placement
Davis Polk advised the representatives of the several underwriters in connection with an initial public offering of 10,592,106 shares of Class A common stock of Seer, Inc. at $19.00 per…
Array Technologies $1.2 billion secondary offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $1.2 billion SEC-registered secondary offering of 36,656,250 shares of…
BeiGene $340 million secondary offering
Davis Polk advised the underwriter in connection with the $340 million SEC-registered offering of 1,511,546 American depositary shares of BeiGene, Ltd. by certain existing ADS holders. The…
Capital Investment Corp. V $345 million IPO
Davis Polk advised the underwriters in connection with the initial public offering of 34,500,000 units of Capitol Investment Corp. V for aggregate proceeds of $345 million, which…
Consonance-HFW Acquisition $80 million IPO
Davis Polk advised the sole book-running manager in connection with the $80 million initial public offering of 8,000,000 units of Consonance-HFW Acquisition Corp. Each unit consists of…
Burger King Brasil R$510 million equity offering
Davis Polk advised the joint bookrunners on the equity offering of common shares of BK Brasil Operação e Assessoria a Restaurantes S.A. for an aggregate amount of approximately R$510…
General Motors Financial $750 million floating-rate notes offering
Davis Polk advised the book-running manager on an SEC-registered offering by General Motors Financial Company, Inc. of its $750 million aggregate principal amount of its floating-rate…
Five Prime Therapeutics $173 million follow-on offering
Davis Polk advised the joint-bookrunning managers and representatives of the several underwriters in connection with an approximately $173.8 million public offering of common stock by…
Atea Pharmaceuticals $345 million IPO
Davis Polk advised the representatives of the underwriters in connection with the $345 million initial public offering of 14,375,000 shares of common stock of Atea Pharmaceuticals, Inc.,…